Company Encyclopedia
View More
name
Sotera Health
SHC.US
Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer.
770.89 B
SHC.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking28/60
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE10.86%B
    • Profit Margin4.82%C
    • Gross Margin57.04%B
  • Growth ScoreC
    • Revenue YoY2.67%C
    • Net Profit YoY-21.38%D
    • Total Assets YoY1.19%C
    • Net Assets YoY17.08%A
  • Cash ScoreB
    • Cash Flow Margin2075.90%A
    • OCF YoY2.67%C
  • Operating ScoreC
    • Turnover0.36C
  • Debt ScoreE
    • Gearing Ratio82.72%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Shareholder Warburg Pincus Llc Files To Sell 9,720,000 Of Sotera Health Co [SHC]

    Warburg Pincus Llc, a shareholder of Sotera Health Co, filed a Form 144 with the SEC to sell 9,720,000 restricted shares on December 3, 2025. The sale will be brokered by Goldman Sachs & Co. Filing Form 144 allows the sale within 90 days.

    Reuters·
    US
    SHC
    -1.66%
    Reuters·
    US
    SHC
    -1.66%

    Jefferies Keeps Their Buy Rating on Sotera Health (SHC)

    Jefferies analyst David Windley maintained a Buy rating on Sotera Health (SHC) with a price target of $19.50. Windley, a 5-star analyst, has an average return of 9.3% and a 59.60% success rate. Sotera Health also received a Buy rating from BMO Capital's Sean Dodge, while Piper Sandler maintained a Hold rating.

    Tip Ranks·
    US
    SHC
    -1.66%
    Tip Ranks·
    US
    SHC
    -1.66%

    Major Sotera Health Stock Sell-Off by Key Directors!

    Sotera Health (SHC) directors have sold significant shares, with Warburg Pincus & Co. offloading 18 million shares worth $281.7 million and GTCR INVESTMENT XI LLC selling 12 million shares valued at $187.8 million. Despite these sales, analysts have raised price targets following strong Q3 2025 results, driven by Nordion and Sterigenics. Sotera Health announced a secondary offering of 30 million shares, managed by Goldman Sachs. TipRanks' AI Analyst rates SHC as Neutral, citing strong earnings but concerns over high debt and litigation risks.

    Tip Ranks·
    US
    SHC
    -1.66%
    Tip Ranks·
    US
    SHC
    -1.66%

    GTCR Investment XI LLC Reports Sale of Sotera Health Co. Common Shares

    GTCR Investment XI LLC has reported the sale of common shares of Sotera Health Co. as per a recent SEC filing. The transaction involved multiple reporting persons, including GTCR Partners XI/A&C and members of the GTCR Board of Managers. The full filing is accessible through the provided link. This news brief is generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice.

    Reuters·
    US
    SHC
    -1.66%
    Reuters·
    US
    SHC
    -1.66%

    BMO Capital’s Buy Rating on Sotera Health: Positive Outlook Amid Growth Resurgence and Strategic Strengths

    BMO Capital has initiated a Buy rating on Sotera Health (SHC), citing a positive outlook driven by the easing of macroeconomic challenges and expected revenue growth of 5-7%. The company's strong pricing power, potential market share gains from new regulations, and effective cost management contribute to this optimism. Despite ongoing litigation risks, BMO believes the stock's current valuation offers upside potential. Barclays also maintains a Buy rating with a $20 price target.

    Tip Ranks·
    US
    SHC
    -1.66%
    Tip Ranks·
    US
    SHC
    -1.66%
    © 2025 Longbridge｜Disclaimer